Table 3.
Recommend agonist concentrations to be used for inhibitor screening
| Cell type/Target receptor | Endogenous agonist | Concentration (1 X) |
|---|---|---|
| CHO-C5aR1 | hC5a | 0.3 nM |
| CHO-C3aR | hC3a | 0.3 nM |
| HMDM (C5aR1) | hC5a | 1 nM |
| HMDM (C3aR) | hC3a | 5 nM |
Recommend agonist concentrations to be used for inhibitor screening
| Cell type/Target receptor | Endogenous agonist | Concentration (1 X) |
|---|---|---|
| CHO-C5aR1 | hC5a | 0.3 nM |
| CHO-C3aR | hC3a | 0.3 nM |
| HMDM (C5aR1) | hC5a | 1 nM |
| HMDM (C3aR) | hC3a | 5 nM |